gvtcx

Lecanemab Homecare Service

University College London Hospitals NHS FT Published 19 Feb 2025 Find a Tender

key details

Value£816,000
Statusactive
Category (CPV) 85149000
RegionLondon
Deadline26 Mar 2025
Procedureopen
OCIDocds-h6vhtk-04e3d2

description

Direct supply and administration of Lecanemab (Leqembi) in a patient’s home, via a homecare delivery service. Lecanemab is indicated for the treatment of mild cognitive impairment and mild dementia due to Alzheimer's disease in adult patients that are apolipoprotein E ε 4 (ApoE ε 4) heterozygotes or non-carriers. The service is being offered by UCLH private Healthcare and will be for private patients only.

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
19 Feb 2025 Contract notice (F02) Earlier regulations 005785-2025

more from University College London Hospitals NHS FT

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Find a Tender. Contact details for named individuals are not reproduced on this site.